Carcinogenic N-hydroxylaminopurine derivatives do not act as base analog mutagens in Salmonella typhimurium

Mutation Research Letters - Tập 144 Số 4 - Trang 231-237 - 1985
Michael A. McCartney1, Elena C. McCoy1, Herbert S. Rosenkranz1, Alfredo Giner‐Sorolla2
1Center for the Environmental Health Sciences, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, U.S.A.
2Department of Pharmacology, University of South Florida College of Medicine, Tampa, FL 33612 U.S.A.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Alderson, 1964, The mutagenic activity of 2-aminopurine and 2,6-diaminopurine on phage T4 grown on non-inhibited and chloramphenicol inhibited cells of Escherichia coli B, Mutation Res., 1, 205, 10.1016/0027-5107(64)90024-7

Ames, 1975, Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test, Mutation Res., 31, 347, 10.1016/0165-1161(75)90046-1

Barner, 1982, Base-sequence analysis of his+ revertants of the his G46 missense mutation in Salmonella typhimurium, Environ. Mutagen., 4, 297

Barrett, 1981, Induction of gene mutation in and cell transformation of mammalian cells by modified purine: 2-Aminopurine and 6-N-hydroxylaminopurine, 78, 5685

Beland, 1983, Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis, Environ. Health Perspect., 49, 125, 10.1289/ehp.8349125

Benzer, 1961, On the topography of the genetic fine structure, 47, 403

Brockman, 1979, Potent mutagenicity of 6-N-hydroxylaminopurine and 2-amino-N6-hydroxyadenine at the ad-3 region of Neurospora crassa, Environ. Mutagen., 1, 133

Burchenal, 1967, Studies on 6-N-hydroxylamino-9-β-d-ribofuranosylpurine inmouse leukemia, Biochem. Pharmacol., 16, 423, 10.1016/0006-2952(67)90089-5

Clive, 1979, Validation and characterization of the L5178Y/TK+/− mouse lymphoma mutagen assay system, Mutation Res., 59, 61, 10.1016/0027-5107(79)90195-7

Dunkel, 1984, Reproducibility of microbial mutagenicity assays, I. Tests with Salmonella typhimurium and Escherichia coli using a standardized protocol, Environ. Mutagen., 6, 1, 10.1002/em.2860060702

Freese, 1959, The difference between spontaneous and base analogue induced mutations of phage T4, 45, 622

Freese, 1968, The mutagenic effect of hydroxyaminopurine derivatives on phage T4, Mutation Res., 5, 299, 10.1016/0027-5107(68)90028-6

Giner-Sorolla, 1958, Synthesis and properties of some 6-substituted purines, J. Am. Chem. Soc., 80, 3932, 10.1021/ja01548a033

Giner-Sorolla, 1966, Synthesis and biological activity of 9-β-d-ribo-furanosyl-6-N-hydroxylaminopurine, J. Med. Chem., 9, 143, 10.1021/jm00319a035

Giner-Sorolla, 1966, The synthesis and properties of substituted 6-hydroxylaminopurines, Biochemistry, 5, 3057, 10.1021/bi00873a039

Giner-Soralla, 1968, The synthesis and biological properties of hydroxylaminopurines and related derivatives, J. Med. Chem., 11, 521, 10.1021/jm00309a025

Giner-Sorolla, 1972, Hydroxylaminopurines: Synthesis, physicochemical properties and biological activity, 478

Howard, 1983, Formation of DNA adducts in vitro and in Salmonella typhimurium upon metabolic reduction of the environmental mutagen 1-nitropyrene, Cancer Res., 43, 2052

Isono, 1974, Chemical carcinogens as frameshift mutagens: Salmonella DNA sequence sensitive to mutagenesis by polycyclic carcinogenesis, 71, 1612

Janion, 1978, The efficiency and extent of mutagenic activity of some new mutagens of base analogues type, Mutation Res., 56, 225, 10.1016/0027-5107(78)90189-6

Janion, 1981, Mutagenic and inhibitory properties of some new purine analogs on Salmonella typhimurium TA1530, Mutation Res., 91, 193, 10.1016/0165-7992(81)90030-0

Levin, 1982, A new Salmonella tester strain (TA102) with A·T base pairs at the site of mutation detects oxidative mutagens, 79, 7445

MacPhee, 1983, Mutagenesis and anti-mutagenesis in Salmonella: influence of ethionine and caffeine on yields of mutations induced by 2-aminopurine and 9-aminoacridine, Mutation Res., 111, 283, 10.1016/0027-5107(83)90027-1

Maron, 1983, Revised methods for the Salmonella mutagenicity test, Mutation Res., 113, 173, 10.1016/0165-1161(83)90010-9

Massaro, 1983, Evidence that nitroarene metabolites form mutagenic adducts with DNA-adenine as well as with DNA-guanine, Mutation Res., 122, 243, 10.1016/0165-7992(83)90002-7

McCoy, 1981, 4-Nitroquinoline-1-oxide: Factors determining its mutagenicity in bacteria, Mutation Res., 89, 151, 10.1016/0165-1218(81)90121-X

McCoy, 1983, The basis of the insensitivity of Salmonella typhimurium strain TA98/1,8-DNP6 to the mutagenic action of nitroarenes, Mutation Research, 121, 17, 10.1016/0165-7992(83)90081-7

Ronen, 1979, 2-Aminopurine, Mutation Res., 75, 1, 10.1016/0165-1110(80)90026-3

Rosenkranz, 1983, Mutagencity and genotoxicity of nitroarenes: All nitro-containing chemicals were not created equal, Mutation Res., 114, 217, 10.1016/0165-1110(83)90034-9

Rosenkranz, 1985, Environmental nitroarenes: An attempt to understand their mutagenic and carcinogenic properties, Vol. IV

Sorenson, 1981, Comparison of mutagenic and recombinogenic effects of some adenine analogues in Saccharomyces cerevisiae D7, Mutation Res., 82, 95, 10.1016/0027-5107(81)90141-X

Sugiura, 1970, A comparison of the oncogenicities of 3-hydroxyxanthine guanine-3-oxide and some related compounds, Cancer Res., 30, 184

Trainin, 1964, Influence of mutagens on the initiation of skin carcinogenesis, Biochem. Pharmacol., 13, 263, 10.1016/0006-2952(64)90144-3